Blog
Why Rivian, Lucid, and ChargePoint Lost Early Gains Today
The stocks of electric vehicle (EV) sector companies jumped Thursday morning with news that indicated the market looks to continue to grow at a fast pace. But after each popping at least 5%, shares
Tesla's Earnings Report Reveals 2 Major Catalysts
Tesla's (NASDAQ: TSLA) fourth-quarter earnings report showed that the electric-car maker wrapped up 2022 with impressive momentum. Fourth-quarter revenue grew 33% and net income for the same period
Is Verizon's Dividend Safe After Q4 Earnings?
Verizon (NYSE: VZ) surprised investors with excellent wireless customer growth in the fourth quarter. The figures indicate Verizon's robust dividend is well supported.
*Stock prices used were the
Best Stock to Buy: Amazon Stock vs. Alphabet Stock
Amazon (NASDAQ: AMZN) and Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) are dominant in their respective fields. Unsurprisingly, investors are curious about which of these incredible growth stocks is
Chevron Is Returning More of Its Oil-Fueled Windfall to Shareholders. Time to Buy This Oil Stock?
Chevron (NYSE: CVX) reported record earnings and cash flow last year, fueled by higher oil and gas prices. That's giving the oil giant more money to return to shareholders. As a result, it's
The Case for Lemonade Stock in 2023
Motley Fool contributor Jamie Louko keeps a small Lemonade (NYSE: LMND) stock position. At this early stage, he sees investing in Lemonade as a bet on its superior insurance customer experience.
Why Sherwin-Williams Stock Is Down Today
Sherwin-Williams (NYSE: SHW) posted slightly better-than-expected earnings for the fourth quarter, but the company's outlook for 2023 was well short of what investors had expected. The market is
Got $1,000? 2 Heavily Discounted Nasdaq Stocks to Buy and Hold Forever
Through the power of compounding, you don't actually need a whole lot of capital to start investing in stocks. Top growth stocks, after all, can turn even a modest amount like $1,000 into $3,000 or
This Supercharged Dividend Stock Is a No-Brainer Buy Right Now
NextEra Energy Partners (NYSE: NEP) is a unicorn among dividend stocks. It offers a well-above-average dividend yield of 4.5% after its recent boost, versus 1.7% for the S&P 500. Meanwhile, it's
2 Solid Growth Stocks That Are Cheaper Than They Look
One painful mistake investors can make is to rely too much on stock screeners when looking for possible investments. For example, if they start their search by filtering out stocks with high
Could This New Drug Indication Be a Winner for Eli Lilly?
Eli Lilly (NYSE: LLY) and Boehringer Ingelheim's supplemental New Drug Application for Jardiance tablets to treat adult patients with chronic kidney disease (CKD) was recently accepted for review by
Unity Software Stock Is Speculative. Here's Why I Own It Anyway
Motley Fool contributor Jamie Louko breaks down Unity (NYSE: U), including its strongest advantages and toughest struggles lately. A mediocre acquisition further solidifies Unity as part of Jamie's
Where Will Wayfair Stock Be in 1 Year?
Wayfair's (NYSE: W) stock closed at its all-time high of $345.47 on March 22, 2021. At the time, the online furniture and home goods retailer seemed like a solid play on soaring home sales and
Tesla Stock Jumps on Earnings Release: 8 Key Metrics You Should See
Tesla (NASDAQ: TSLA) stock is up 7.7% in Thursday's premarket trading as of 8:30 a.m. ET, following the electric vehicle (EV) pioneer's release of a strong fourth-quarter 2022 report the prior
2 Market-Beating Stocks to Buy in 2023 and Hold for 10 Years
What will the world look like in a decade? It's hard to predict that with great accuracy, but for investors it's helpful to focus on the knowledge that the stock market has generally generated solid
Here's My Top Growth Stock to Buy Now
There are some restaurant concepts that just click with consumers, and those businesses can turn into long-term growth machines. This has been the case for Chipotle Mexican Grill (NYSE: CMG).
3M's Earnings Were Mixed, But the Stock Is Cheap
3M (NYSE: MMM) reported earnings this week, and the results were mixed. Margins are down, and guidance was weak enough to cause management to announce layoffs. But despite the challenges, this is a
Netflix's Q4 Subscriber Growth Clearly Came at a Cost
The good news is that Netflix (NASDAQ: NFLX) added nearly 7.7 million paying customers during the fourth quarter of last year, handily topping expectations. The bad news is that net subscriber
3 Warren Buffett Stocks That Could Make You Richer in 2023
Berkshire Hathaway CEO Warren Buffett is widely considered one of the best stock pickers of all time, and for good reason. By focusing primarily on a company's intrinsic value and its competitive
The 1 Reason I Still Own Upstart Stock
For Motley Fool contributor Jamie Louko, the case for owning Upstart (NASDAQ: UPST) comes down to just one metric. And so far, this AI-powered company is delivering.
*Stock prices used were the
Is It Too Late to Buy Eli Lilly Stock?
Eli Lilly (NYSE: LLY) is a top healthcare company, and it has generated mild but consistent growth over the years. And during the past decade, its share price has increased by more than 550%. While
3 Tech Stocks With More Potential Than Any Cryptocurrency
We learned in 2022 that some parts (maybe all?) of the cryptocurrency industry are built as a house of cards. When the foundations were found to be flimsy, the collapse didn't take long and several
3 Cathie Wood Stocks to Buy in 2023
"Fear of the future is palpable, but crisis can create opportunities." Those were Cathie Wood's words from a letter she wrote and posted on the Ark Invest website earlier this month. Considering the
1 Stock Slated for a Jaw-Dropping Recovery in 2023
Software-as-a-service (SaaS) stocks had an atrocious 2022. Unfortunately, much of that was self-inflicted, especially considering the lofty valuations many stocks reached during their late 2021
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
Shareholders of Catalyst Pharmaceuticals (NASDAQ: CPRX) got a nasty shock on Jan. 23 when the company reported that a competitor, Teva Pharmaceutical Industries (NYSE: TEVA), was planning to make a


